[1. Lavebratt C, Alpman A, Persson B, Arner P, Hoffstedt J. Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men. Int J Obes. 2006; 30(3): 453-459.10.1038/sj.ijo.080318816331299]Search in Google Scholar
[2. Suchanek P, Kralova-Lesna I, Pledne R, Lanska V, Hubacek JA. An AHSG gene variant modulates baal metabolic rate and body composition development after a short-time lifestyle intervention. Neuroendocrinol Lett. 2011; 32(suppl 2): 32-36.]Search in Google Scholar
[3. Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, Kere J, et al. a2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia. 2004; 47(11): 1974-1979.10.1007/s00125-004-1556-715599699]Search in Google Scholar
[4. Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F. A synonymous coding polymorphism in the a2-Here-mans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes. 2005; 54(8): 2477-2481.10.2337/diabetes.54.8.247716046317]Search in Google Scholar
[5. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, et al. a2-Heremans-Schmid glyco-protein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006; 29(4): 853-857.10.2337/diacare.29.04.06.dc05-193816567827]Search in Google Scholar
[6. Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, et al. Association of AHSG gene polymor-phisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009; 2(6): 607-613.10.1161/CIRCGENETICS.109.87041020031641]Search in Google Scholar
[7. Muendlein A, Stark N, Rein P, Saely CH, Geller- Rhomberg S, Geiger K, et al. Are AHSG polymorphisms directly associated with coronary atherosclerosis? Clin Chim Acta. 2012; 413(1-2): 287-290.10.1016/j.cca.2011.10.00822024217]Search in Google Scholar
[8. Andersen G, Burgdorf KS, Sparsø T, Borch- Johnsen K, Jørgensen T, Hansen T, et al. AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects. Diabetes. 2008; 57(5): 1427-1432.10.2337/db07-055818316360]Search in Google Scholar
[9. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the AHSG gene. Diabetes. 2002; 51(8): 2450-2458.10.2337/diabetes.51.8.245012145157]Search in Google Scholar
[10. Ganjavi H, Shapiro CM. Hypocretin/Orexin: a molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci. 2007; 19(4): 413-419.10.1176/jnp.2007.19.4.41318070844]Search in Google Scholar
[11. Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, et al. Structure and function of human prepro-orexin gene. J Biol Chem. 1999; 274(25): 17771-17776.10.1074/jbc.274.25.1777110364220]Search in Google Scholar
[12. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus- specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998; 95(1): 322-327.10.1073/pnas.95.1.322]Search in Google Scholar
[13. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998; 92(4): 573-585.10.1016/S0092-8674(00)80949-6]Search in Google Scholar
[14. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, et al. Genetic ablarton of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuwron. 2001; 30(2): 345-354.]Search in Google Scholar
[15. Bronsky J, Nedvidkova J, Zamrazilova H, Pechova M, Chada M, Kotaska K, et al. Dynamic changes of orexin A and leptin in obese children during body weight reduction. Physiol Res. 2007; 56(1): 89-96.10.33549/physiolres.93086016497092]Search in Google Scholar
[16. Adam JA, Menheere PPCA, Van Dielen FMH, Soeters PB, Buurman WA, Greve JWM. Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord. 2002; 26(2): 274-276.10.1038/sj.ijo.080186811850761]Search in Google Scholar
[17. Kok SW, Meinders AE, Overeem S, Lammers GJ, Roelfsema F, Frölich M, et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab. 2002; 87(2): 805-809.10.1210/jcem.87.2.824611836325]Search in Google Scholar
[18. Hungs M, Lin L, Okun M, Mignot E. Polymorphisms in the vicinity of the hypocretin/orexin are not associated with human narcolepsy. Neurology. 2001; 57 (10): 1893-1895.10.1212/WNL.57.10.189311723284]Search in Google Scholar
[19. Ammar DA, Eadie DM, Wong DJ, Ma Y-Y, Kolakowski LF Jr, Yang-Feng TL, et al. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 1996; 38(3): 392 398.10.1006/geno.1996.06428975716]Search in Google Scholar
[20. Chen C-H, Stephens RL Jr, Rogers RC. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Mot. 1997; 9(2): 109-116.10.1046/j.1365-2982.1997.d01-26.x9198086]Search in Google Scholar
[21. Siddiq A, Gueorguiev M, Samson C, Hercberg S, Heude B, Levy-Marchal C, et al. Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects. Diabetologia. 2007; 50(3): 574-584.10.1007/s00125-006-0555-217235527]Search in Google Scholar
[22. Hunt SC, Hasstedt SJ, Xin Y, Dalley BK, Malish BA, Yakobson E, et al. Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity. 2011; 19(11): 2241-2247.10.1038/oby.2011.239373317321818152]Search in Google Scholar
[23. Hung Ch-ChC, Pirie F, Luan J, Lank E, Motala A, Yeo GSH, et al. Studies of the peptide YY and neuropep-tide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes. 2004; 53(9): 2461-2466.10.2337/diabetes.53.9.246115331560]Search in Google Scholar
[24. Tunstall-Pedoe H. MONICA’s quarter century. Eur J Cardiovasc Prev Rehabil. 2003; 10(6): 409-410.10.1097/01.hjr.0000102816.74402.1214671462]Search in Google Scholar
[25. Thunsdall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S. MONICA monograph and multimedia sourcebook. Thunsdall-Pedoe H, Ed. Geneva: World Health Organization, 2003.]Search in Google Scholar
[26. Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, et al. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb. 2010; 17(9): 925-933.10.5551/jat.383020543523]Search in Google Scholar
[27. Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol. 2012; 64(12): 1703-1708. 10.1111/j.2042-7158.2012.01561.x23146032]Search in Google Scholar